Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Covington
Argus Health
Fuji
Teva
Cerilliant
McKesson
Johnson and Johnson
Fish and Richardson

Generated: January 19, 2018

DrugPatentWatch Database Preview

NAFTIFINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Naftifine Hydrochloride, and when can generic versions of Naftifine Hydrochloride launch?

Naftifine Hydrochloride is a drug marketed by Taro and Tolmar and is included in three NDAs.

The generic ingredient in NAFTIFINE HYDROCHLORIDE is naftifine hydrochloride. There are eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the naftifine hydrochloride profile page.
Summary for NAFTIFINE HYDROCHLORIDE
Drug patent expirations by year for NAFTIFINE HYDROCHLORIDE
Pharmacology for NAFTIFINE HYDROCHLORIDE
Ingredient-typeAllylamine
Drug ClassAllylamine Antifungal

US Patents and Regulatory Information for NAFTIFINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro NAFTIFINE HYDROCHLORIDE naftifine hydrochloride CREAM;TOPICAL 205975-001 Sep 8, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Taro NAFTIFINE HYDROCHLORIDE naftifine hydrochloride CREAM;TOPICAL 206901-001 Jan 6, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Tolmar NAFTIFINE HYDROCHLORIDE naftifine hydrochloride CREAM;TOPICAL 206960-001 Apr 10, 2017 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Harvard Business School
Citi
Dow
Covington
Novartis
Mallinckrodt
Cipla
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot